Siemens’ IQ•SPECT Technology Nets FDA Clearance
December 12, 2008 – IQ•SPECT is the newest Symbia feature from Siemens Healthcare that reportedly enables a comprehensive cardiac evaluation including perfusion, attenuation correction and calcium scoring in just five minutes.
Achieved with SMARTZOOM collimators that magnify the heart while imaging the rest of the torso under traditional conditions, IQ•SPECT technology combines this cardio-centric orbit acquisition technique with fast, 3D iterative reconstruction to enable more confident diagnoses and improved patient comfort, enhancing image quality, speed, productivity and throughput.
IQ•SPECT is 510k-cleared and commercially available on all Symbia S and T systems, and is field upgradeable for any existing systems.
For more information: www.siemens.com/healthcare